Explore the innovative concept of bioengineered lymph nodes as a promising solution for lymphedema after cancer surgery.

Please provide your email address to receive an email when new articles are posted on . Up to 88% of sentinel lymph node biopsies (SNLB) return with a negative result. The DecisionDx-Melanoma test, ...

New research led by King's College London suggests that a simple test already used in clinics could provide valuable ...

Patients identified as low risk by DecisionDx-Melanoma had a 2.8% sentinel lymph node (SLN) positivity rate, well below the National Comprehensive Cancer Network® (NCCN) guidelines’ 5% threshold to ...

ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph nodes — a finding that could ...

TAMPA, Fla. (Oct. 22, 2025) — A large multicenter clinical trial published in JAMA Surgery shows that a gene expression profile–based test can reliably identify melanoma patients who have a low risk ...

Researchers developed bioengineered lymphatic tissue that replaced missing lymph nodes in mice, with potential to treat lymphedema.

Lymphoma in the legs can cause swelling and skin rashes in addition to fever, unintentional weight loss, and fatigue. Treatment may include chemotherapy, radiation, and stem cell transplants. Your ...